Gleason Group’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,250
Closed -$9K 243
2022
Q3
$9K Hold
4,250
﹤0.01% 184
2022
Q2
$7K Hold
4,250
﹤0.01% 186
2022
Q1
$21K Buy
+4,250
New +$21K 0.01% 152